hotspot -WSS

hotspot

author：fashion 2025-10-04 07:15:39 - browse：739

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Alkermes shareholders re
Next article： Why health care costs have stayed mostly flat since 2010

explore

WSS

FDA's naming rule on biosimilars has undermined competition

Eliminate the waiting period for sterilization covered by Medicaid

Medicare drug price negotiation hasn't dried up venture capital

SEC charges former device maker CEO with $41 million fraud

Grail spinoff by Illumina should end disastrous merger attempt

Medicare Advantage beneficiaries sue Humana over algorithm use

Wikipedia

hotspot

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA's naming rule on biosimilars has undermined competition

Medical leaders decry Supreme Court decision on affirmative action

Steward Health Care has deal to sell doctor network to UnitedHealth

In Memoriam: Notable people who died in 2023

Will generative AI in health care meet the fate of IBM's Dr. Watson?

BioMarin wins approval for gene therapy to treat hemophilia A

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Peter Hotez and the public health issue of online harassment

HCA sued by state AG for quality issues at Mission Health

hotspot

Study says nonprofit hospitals fall short in charity care spending

Why the world’s most expensive drug might be worth the price

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Medicare drug price negotiation hasn't dried up venture capital

Three trends to watch in biotech in 2024

knowledge

explore

explore

leisure time